GlassScriptPhysician profile
Jason Edward Maxa
NPI 1093778185
$519.82
in general payments reported to CMS, 2019-2025
11 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $183 · 2023: $58.72 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $157.63 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $73.56 | 2021-2023 | Stravix |
| Ferring Pharmaceuticals INC. | $66.04 | 2021-2022 | |
| Pacira Therapeutics, INC. | $53.14 | 2021 | |
| Depuy Synthes Sales INC. | $35.52 | 2022-2025 | Na |
| Acera Surgical, INC. | $33.13 | 2025 | Restrata Wound Matrix |
| Kowa Pharmaceuticals America, INC. | $28.44 | 2022 | |
| Heron Therapeutics, INC. | $25.86 | 2025 | Zynrelef |
| Kerecis Limited | $18.71 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $13.96 | 2022 | |
| Solventum Corporation | $13.83 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Maxa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.